Container Closure and Integrity Testing

Coriolis Pharma offers industry-leading container closure integrity (CCI) testing services to ensure the sterility and stability of your drug products throughout their shelf life. Utilizing our scientific expertise and state-of-the-art technologies, we provide comprehensive CCI testing solutions that support your regulatory compliance and product safety requirements.

Container Closure Selection and Integrity Testing Tailored to Your Needs

Coriolis offers comprehensive testing of the container closure and the integrity of primary packaging materials, including rubber-stoppered glass vials, prefilled syringes and double-chamber cartridges. We also screen different primary packaging formats and products to identify the most suitable option for your drug product and production process.

Glass Vials and Rubber Stoppers

Glass vials are commonly used as a versatile primary container for biopharmaceuticals. Both liquid and lyophilized formulations can be stored, whereas the latter are also freeze-dried directly inside the vial. We utilize a range of analytical techniques, many of them noninvasive, to verify that the oxygen and moisture level inside the headspace of the vial remains unchanged over the intended shelf life and even under accelerated stress conditions, following ICH guidelines or custom conditions.

Evaluation of Prefilled Syringes

Prefilled syringes are often used to enable patient self-administration. Elderly people, rheumatoid patients or children need to be able to use the syringe by themselves but may not be able to apply significant force on the plunger. We test the break-loose and gliding forces of prefilled syringes and double-chamber cartridges and compare different syringe and needle combinations to find the most suitable option for your drug product.

Container Closure, Container Integrity and Primary Packaging Testing Methods

We can select the most suitable approach for your analytical challenge, whether following a standardized in-house workflow or a custom-tailored solution.

Analytical Method Development, Qualification and Validation

For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.

Method Development

Our method development approach tailors sample preparation, method settings and data analysis to the needs of your project and sample.

We include representative samples and, where available, suitable reference standards and stressed/degraded materials, allowing our analytical scientists to design a highly suitable, stability-indicating, robust and repeatable method. Upon request, we will compile a detailed description of the method for your records.

Method Qualification

Method qualification is the initial assessment of an analytical procedure’s performance to show its suitability for its intended purpose.

During method qualification, our analytical scientists perform documented testing demonstrating that the analytical procedure meets criteria in several categories. Criteria may include factors such as repeatability, specificity and robustness. We compile a qualification plan and report, including all relevant data.

Method Validation

Under GMP conditions, method validation confirms that an analytical procedure’s performance suits its intended purpose. Depending on the method’s scope, a broad range of method characteristics, such as specificity, accuracy, precision, limit of detection/limit of quantification (LOD/LOQ), linearity and range, is considered.

During method validation, our analytical scientists perform documented testing demonstrating that the analytical procedure consistently produces a result that meets the predetermined acceptance criteria. We compile a validation plan and report that includes all relevant data.

Depending on the development phase, a fit-for-purpose validation approach can be offered, adjusting the validation required efforts in a phase-appropriate way to meet the method’s needs.

Method Verification

Compendial method verification confirms that a compendial method (e.g., from Ph. Eur. or USP) is suitable and reliable for its intended purpose under the specific conditions of the laboratory.

Unlike full method validation, compendial method verification is often considered a partial validation since the method has already undergone extensive testing and validation during its inclusion in the compendium. The extent of method verification depends on the type of method.

During method verification, our analytical scientists perform documented testing demonstrating that the developed analytical method performs adequately for the specific product or matrix being tested and within the specific laboratory where the method will be employed.

We’ve worked with more than 930 compounds, and that number is growing by the day.

Container Closure and Integrity for Your Drug Product

Coriolis Pharma’s deep expertise across many biologic modalities, combined with input from world-leading external advisors, offers the knowledge and experience needed to solve even the most complex formulation and drug development challenges.

Your Phase

Our expert team has the expertise and experience to guide your biopharmaceutical development program from preclinical and early-phase development to the market.

Coriolis Effect

See how our expertise and comprehensive services accelerate biologics development from preclinical to the market.

Container Closure Integrity Testing Resources

View All

Talk to Our Experts or Request a Quote

Our expert team is ready to answer your questions and guide you to the services best suited to your program’s modality, stage and challenge. If your needs are well-defined, we’ll begin the quotation process.

Description